0.05Open0.05Pre Close0 Volume4 Open Interest5.00Strike Price0.00Turnover0.00%IV34.26%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-3DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma150.60Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Allot Stock Discussion
O2 Czech Republic Launches Allot Solution to Offer Consumer Cybersecurity Services
Thursday, 9th January at 5:06 am
Hod Hasharon, Israel, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative network intelligence and converged network-native security solutions for communication service providers and enterprises, today announced that O2 Czech Republic, a subsidiary of the PPF Group, has launched Allot DNS Secure, ena...
Allot Announces its New Service Gateway Tera III for Top Tier Telecom Operators
Allot (NASDAQ: ALLT) has unveiled its new Service Gateway Tera IIImultiservice platform, boasting the highest capacity in the telecommunications market at 2.8 Tbps. The platform delivers scalable carrier-grade performance for network intelligence, traffic management, and cybersecurity protection services in a unified solution. The SG-Tera III features up to 26x 400 Gbps ports or 104x 100 Gbps por...
📊⚡️📊
Positive
First non-GAAP operating profit ($1.1M) in three years
SECaaS revenues grew 69% YoY to $4.7M
Revenue increased 5% sequentially and 3% YoY to $23.2M
Non-GAAP gross margin improved to 71.7%
Generated positive operating cash flow of $1.9M
Net cash increased by $2.0M vs previous quarter
Negative
GAAP operating loss of $0.2M
GAAP net loss of $0.2M ($0.01 per share)
$Allot (ALLT.US)$ buy in 7.82 sell 12.25 after 8.23 the gaps are 9.76, 10.40, 11.34, 11.84 12.08.
$Synchronoss Technologies (SNCR.US)$ Buy in 1.59 sell 2.23.
$Puma Biotechnology (PBYI.US)$ buy in 2.72 sell 6.48.
$Avalo Therapeutics (AVTX.US)$ buy in .64. sell 1.76. Institutional investor has continued buying but the price may not have found bottom yet.
No comment yet